ERBB2 and breast carcinoma: Expression of ER, PR and HER2 have a profound effect on breast cancer outcome because of (at least) following reasons: a) signaling through these receptors drive cancer cell growth and proliferation, b) they are key biomarkers to define patient’s BC subtypes and guide the physicians to choose the best treatment regimen.